The nutrient sensor, O-linked N-acetylglucosamine (O-GlcNAc), cycles on and off nuclear and cytosolic proteins to regulate many cellular processes, including transcription and signaling. Dysregulated O-GlcNAcylation and its interplay with phosphorylation contribute to the etiology of diabetes, cancer, and neurodegeneration. Herein, we review recent findings about O-GlcNAc's regulation of cell physiology.
Introduction
Complex molecular mechanisms ensure cellular homeostasis between nutrient sensing and energy metabolism. Strong evidence from many laboratories supports a role for the hexosamine biosynthetic pathway (HBP) and its end product, UDP-GlcNAc, as important nutrient sensors (Bond and Hanover, 2013; Hart et al., 2011; Vaidyanathan et al., 2014) . The biosynthesis of UDP-GlcNAc is regulated by nearly every major metabolic pathway ( Figure 1A ). Production of fructose-6-phosphate by the glycolytic pathway is the first committed step of the HBP. Depending upon the cell type and metabolic state, about 2%-5% of the glucose that enters the cell is directed to the HBP to make UDP-GlcNAc. Amino acid metabolism is linked to flux through the HBP at several steps: via glucose through gluconeogenesis, via glutamine serving as the nitrogen donor to form glucosamine-6-phosphate, and via acetyl-CoA serving as the donor for acetylation of glucosamine-6-phosphate through ketogenesis. Fatty acid metabolism is linked to the HBP via acetyl-CoA as well. The latter is not only essential to fatty acid metabolism but also serves to balance flux between carbohydrates and fatty acids. UTP, which serves as the donor to form UDP-GlcNAc, links flux through the HBP to both energy and nucleotide metabolism. Thus, UDP-GlcNAc sits at a major nexus of cellular metabolic pathways and is responsive to flux through them.
Although UDP-GlcNAc is used for the synthesis of secreted or membrane glycoproteins, where its concentration appears to control branching of complex glycans, the nucleotide sugar also serves as the donor substrate for O-GlcNAc transferase (OGT)-catalyzed O-GlcNAcylation of myriad nuclear, cytoplasmic, and mitochondrial proteins. Although discovered in the early 1980s, O-GlcNAcylation's key roles in cellular regulation are only more recently being widely understood. Unlike phosphorylation that requires over 600 kinases and phosphatases in humans, only two genes encode the enzymes that catalyze O-GlcNAc cycling. OGT catalyzes the transfer of a single O-GlcNAc moiety from UDP-GlcNAc to a serine or threonine residue in proteins, whereas O-GlcNAcase (OGA) removes the O-GlcNAc. OGT enzymatic activity is not only highly responsive to UDP-GlcNAc across a very broad range of concentrations, but also its substrate specificity is dependent upon the concentration of the nucleotide sugar (Shen et al., 2012) . UDP-GlcNAc concentrations vary dramatically between tissues, during differentiation, during inflammation, and in response to stimuli and nutrient availability. OGT is therefore a ''control center'' that integrates metabolic flux to send signals to effectors via O-GlcNAcylation.
This short review cannot summarize all the extensive work about O-GlcNAcylation of proteins and their regulation (we refer interested readers to recent comprehensive reviews: Bond and Hanover, 2013; Hart et al., 2011; Ma and Hart, 2013; Vaidyanathan et al., 2014) . Here we discuss only very recent findings that illustrate how OGT and O-GlcNAcylation regulate key downstream effectors to modulate cell physiology in response to nutrients.
Nutrient Regulation of Signaling via O-GlcNAcylation
Crosstalk between protein phosphorylation and O-GlcNAcylation at the same or proximal sites on proteins or by one modification regulating the other's cycling enzymes is extensive and well documented ( Figure 1B) . Competition for the same or nearby site has been previously described for c-Myc, estrogen receptor b (ERb), C-terminal domain (CTD) of the RNA polymerase II, p53, forkhead box O1 (FoxO1), calcium/calmodulin-dependent protein kinase IV (CamKIV), casein kinase 2 (CK2), period 2 (PER2), and many other proteins. The interplay between O-GlcNAcylation and phosphorylation can also occur at more distant sites on proteins, which has been previously shown for cytokeratins. Both O-GlcNAc and O-phosphate may also exist simultaneously on the same protein at different sites, as seen on insulin receptor substrate (IRS), cardiac myosin light chain, or AMP-activated protein kinase (AMPK). Finally, phosphorylation can enhance O-GlcNAcylation, such as has been shown for cAMP response element-binding protein (CREB) (Bullen et al., 2014; Hart et al., 2011; Kaasik et al., 2013; Tarrant et al., 2012) .
Recent glycomic and phosphoproteomic analyses indicate that the interplay between O-GlcNAcylation and phosphorylation are more extensive and complex than previously anticipated. Both OGT and OGA have been found in complexes with kinases or phosphatases, suggesting that they are acting within molecular complexes able to both phosphorylate and/or O-GlcNAcylate. Integration of cell stimuli and signals, as well as nutrient availability, determines which posttranslational modifications (PTMs) are added to polypeptides ( Figure 1B Figure 1C) . O-GlcNAcylation of CamKIV at S189 inhibits its phosphorylation at T200 and blocks its ability to bind ATP and to catalyze phosphorylation (Hart et al., 2011) . Since the Km for UDP-GlcNAc of OGT with CamKIV is over 20 mM, it was proposed that in vivo OGlcNAcylation of CamKIV could vary significantly in response to the rate of HBP flux (Shen et al., 2012) . Calcium/Calmodulindependent protein kinase II (CaMKII) is a multifunctional serine/ threonine kinase important for a variety of cellular functions, including cell division, differentiation, cardiac contraction, and synaptic plasticity. During hyperglycemia, as occurs in diabetes, O-GlcNAcylation of CaMKII is increased in the heart and brain of rats and humans. Its O-GlcNAcylation at S279 leads to an autonomous constitutive activation even after Ca 2+ concentration de- clines (Erickson et al., 2013) , contributing to diabetic cardiomyopathy. Recently, it has been shown that CaMKII is activated by glucagon and fasting in vivo in a calcium-and IP3R-dependent manner. Activated CaMKII stimulates hepatic glucose production through FoxO1 phosphorylation. In obese mice, hepatic CaMKII remains activated and mediates hepatic glucose production (Ozcan et al., 2012) . Owing to the tight relationship between obesity, type II diabetes and O-GlcNAcylation, it is possible that CaMKII O-GlcNAcylation might also contribute to the abnormal enhanced hepatic glucose production associated with diabetes and obesity, as has already been shown for O-GlcNAcylation of PPARg coactivator-1-alpha (PGC-1a), FoxO1, and CREB-regulated transcription coactivator 2 (CRTC2) transcription factors. O-GlcNAcylation also controls the substrate specificity of certain kinases. CK2 is a serine/threonine kinase that regulates cell physiology via the phosphorylation of hundreds of proteins involved in several major cellular processes such as cell cycle, apoptosis, or cell differentiation. Although its regulation remains poorly understood, it has been shown that the CK2a subunit is O-GlcNAcylated at S347. This modification inhibits its phosphorylation at T344 by Cdk1/Cyclin B and impairs its stabilization. In vitro assays using protein microarrays found the surprising result that although O-GlcNAcylation of CK2a doesn't affect its catalytic activity, it does regulate its substrate specificity (Tarrant et al., 2012) . In vitro analyses of the OGT affinity toward CK2 suggest that its substrate selectivity may be nutrient sensitive depending on its O-GlcNAcylation state (Lubas and Hanover, 2000) .
In turn, there is evidence showing that enzymes that govern O-GlcNAc cycling are substrate for kinases. Although OGT and OGA are both phosphorylated, the role of the phosphorylation of OGA remains unknown. Phosphorylation by insulin receptor, CaMKIV, glycogen synthase kinase 3 beta (GSK3b), and AMPK (Bullen et al., 2014; Hart et al., 2011; Kaasik et al., 2013) . Phosphorylation and O-GlcNAcylation are in competition for the modification of the residues S3 or S4 of OGT, and it has been shown that phosphorylation by GSK3b at these residues enhances OGT activity (Kaasik et al., 2013) . AMPK is an energy sensor protein kinase activated in response to reduction of intracellular ATP levels. AMPK regulates hundreds of substrates involved in energy metabolism by phosphorylation. It was recently shown that T444 of OGT is phosphorylated by AMPK, and it appears that this modification regulates OGT substrate selectivity (Bullen et al., 2014) . Considering that the activity of AMPK is positively regulated by O-GlcNAcylation (Xu et al., 2014) , these results suggest a regulatory feedback control of AMPK through O-GlcNAcylation, giving a key role to OGT/AMPK in the regulation of energy metabolism.
While there is still much to learn, it is already clear that nutrient regulation of signaling pathways via O-GlcNAcylation impacts nearly all regulatory mechanisms and cellular physiology.
Fundamental Importance of O-GlcNAcylation to Transcription
While regulation of gene expression by hormones, growth factors, and tissue-specific factors is fairly well established, the regulation of gene expression by nutrients is not well understood. The first evidence linking O-GlcNAcylation and chromatin regulation emerged in the late 1980s. OGT and O-GlcNAcylation were shown to be highly abundant on chromatin, associated with transcriptionally active loci on polytene chromosomes in Drosophilia, and the CTD of a subset of RNA polymerase is extensively O-GlcNAcylated. More recently, Ogt was shown to be a polycomb gene. The polycomb group proteins are master regulators, repressing the expression of large sets of genes that control tissue patterning during development. In 2011, Myers et al. confirmed the link between OGT and polycomb group proteins in mammals by showing that the polycomb repressive complex 2 is required to maintain normal levels of OGT and for correct cellular distribution of O-GlcNAcylation (Myers et al., 2011) . Deep sequencing technology established that OGT, OGA, and O-GlcNAcylation are enriched at the active site of transcription in thousands of genes in both human and in C. elegans (Deplus et al., 2013; Love et al., 2010) . O-GlcNAcylation regulates many RNA polymerase II transcription factors. Depending upon the transcription factor, the sugar modification regulates their DNA binding activity (e.g., c-Rel, p53, pancreatic-duodenal homeobox factor1), transcriptional activity (e.g., c-Myc, FoxO1, CREB), and/or stability (e.g., mER-b, p53, d-lactoferrin, b-catenin) (Bond and Hanover, 2013; Hardivillé et al., 2010; Olivier-Van Stichelen et al., 2014) .
O-GlcNAcylation also regulates the basal transcriptional machinery. Nearly all of the components of the basal transcription machinery in mammals are modified by O-GlcNAc. The CTD of RNA polymerase II is O-GlcNAcylated at the preinitiation step of the transcription cycle, and the sugar modification is reciprocal to its phosphorylation, which is required for elongation (Figure 2) . O-GlcNAcylation occurs during the preinitiation complex assembly and may regulate the initiation of transcription on a multitude of genes in higher eukaryotes (Bond and Hanover, 2013) .
Epigenetic modifications are heritable changes in chromatin structure that govern temporal and spatial gene expression. O-GlcNAcylation is not only part of the histone code but also influences other epigenetic modifications, such as DNA or histone methylation. All four subunits of the core histones are OGlcNAcylated. Some sites of modification are known: H2A at T101, H2B at S36 and S112, H3 at T32, and H4 at S47 (Vaidyanathan et al., 2014) . Histone O-GlcNAcylation is increased during the G1 phase of the cell cycle, declines during S phase, and increases through G2 and mitosis phases to drop at M/ G1. Although the role of sugar on histone subunits remains poorly understood, some of the O-GlcNAcylation sites directly interact with DNA. O-GlcNAcylation of S112 of histone H2B serves as the docking site for the ubiquitin ligase that modifies H2B K120, which is a transcriptionally active gene mark (Vaidyanathan et al., 2014) . H2B ubiquitination and its ubiquitination complex stimulate H3K4me3 through the SET1/ COMPASS complex. Host cell factor 1 (HCF-1) is an extensively O-GlcNAcylated (19 known attachment sites) component of SET1/COMPASS. OGT not only O-GlcNAcylates HCF-1, but also acts as a unique protease to cleave the protein into its functional fragments by a totally novel protease mechanism involving UDP-GlcNAc in the reaction mechanism (Lazarus et al., 2013) .
Methylation of cytosine is another key epigenetic event critical for various cellular processes and is often associated with transcription repression. Ten-eleven translocation (Tet) family proteins are evolutionarily conserved dioxygenases that convert 5-methylcytosine (5mC) to 5-hydroxylmethylcytosine (5hmC). Hydroxylmethylation of CpG-rich DNA promotes DNA demethylation. Tet1, Tet2, and Tet3 interact strongly with OGT and undergo O-GlcNAcylation (Chen et al., 2013; Deplus et al., 2013; Shi et al., 2013a; Zhang et al., 2014) . Mutation of Tet1 O-GlcNAc sites stabilizes Tet1, and the knockdown of OGT by siRNA reduces the amounts of Tet1 and 5hmC on Tet1 target genes (Shi et al., 2013a) . Interaction between Tet3 and OGT drives Tet3 out of the nucleus, concomitant with decreased 5hmC on DNA. Under pathologic glucose concentrations (25 mM), Tet3 exhibits a cytoplasmic localization, and the HBP inhibitor deoxynorleucine (DON) increases DNA 5hmC content . Conversely, Tet2 and Tet3 colocalize with OGT at promoters, clustered around the transcription start sites and CpG islands, and they overlap at promoters with H3K4me3 (Chen et al., 2013; Deplus et al., 2013) . Depletion of Tet2 reduces O-GlcNAcylation of H2B at S112, suggesting that Tet2 targets OGT to the nucleosome for H2B O-GlcNAcylation (Chen et al., 2013) , supporting the link between DNA methylation and the histone code through OGT and O-GlcNAcylation. Taken together, these studies reveal a central role of OGT and O-GlcNAcylation in basal and genespecific transcription, as well as in the epigenetic modifications on DNA and histones (Figure 2) .
O-GlcNAcylation and Cell Physiology
To maintain proper homeostasis, cell physiology has to adapt to fluctuations in nutrient intake. Cell proliferation, for instance, must be regulated in response to nutrient levels to ensure that sufficient materials are synthesized to generate viable daughter cells. O-GlcNAcylation is intimately linked to the cell cycle since it varies on many proteins all along the cell cycle, and its dysregulation leads to impaired cell cycle progression at major checkpoints (Hart et al., 2011) .
Circadian rhythms are biological oscillations set up by clock transcription factors for a period of about 24 hr. At the cellular level, rhythms in nutrient intake must coincide with fluctuations in gene expression for proper homeostasis. Not surprisingly, nutrient regulation of circadian rhythms is linked to O-GlcNAcylation. Protein O-GlcNAcylation and OGT protein levels peak in the middle of the dark phase in mouse heart. Ogt mRNA levels increased 2 hr before dark, suggesting a regulation of OGT expression by the circadian transcription factors (Durgan et al., 2011) . In the primary feedback loop, the posi- tive elements CLOCK and aryl hydrocarbon receptor nuclear translocator-like (BMAL1) initiate transcription of targeted genes, including PER and cryptochrome (CRY) genes. In return, negative feedback is achieved by PER and CRY repressing transcriptional activity of CLOCK/ BMAL1. BMAL1, CLOCK, PER1, and PER2 are all O-GlcNAcylated (Durgan et al., 2011; Kaasik et al., 2013) . BMAL1 and PER1 appeared to be OGlcNAcylated with a peak in the middle of the dark phase in mouse heart (Durgan et al., 2011) . O-GlcNAcylation stabilizes BMAL1 and CLOCK by inhibiting their ubiquitination, which promotes expression of their target genes (Li et al., 2013) . PER2 can be O-GlcNAcylated at ten different residues, and phosphorylation at S662 inhibits its O-GlcNAcylation. The reciprocal modification of PER2 S662 was shown to be at the core of regulation of PER2 transcriptional repressor activity, with a stronger repressor activity for the O-GlcNAcylated isoform. The OGT inhibitor (Alloxan) or Ogt knockdown (siRNA and Ogt conditional KO mice) shortened the circadian rhythm, while the OGA inhibitor (PUGNAC) lengthened the circadian rhythmicity of PER2-luc oscillation (Durgan et al., 2011; Kaasik et al., 2013) , suggesting that the circadian rhythm is adjusted by O-GlcNAcylation through PER2. Elevated glucose significantly prevents phosphorylation of PER2, even under OGA overexpression (Kaasik et al., 2013) , and knockdown of glutamine-fructose-6-phosphate aminotransferase 1 or Ogt reduces expression of BMAL1 and CRY1 (Li et al., 2013) . These studies suggest that nutrient sensing by the HBP entrains circadian rhythm via O-GlcNAcylation of the core circadian clock transcription factors. Likewise, circadian oscillation is involved in the control of nutrient homeostasis. A recent study showed Cell Metabolism 20, August 5, 2014 ª2014 Elsevier Inc. 211
Cell Metabolism that knockout of Bmal1, which disrupts the clock rhythmicity, leads to profound insulin resistance, hyperglycemia, and fat accumulation in mice (Shi et al., 2013b) . Since OGT modulates the diurnal rhythm of glucose homeostasis (Li et al., 2013) , it is possible that O-GlcNAcylation could be the molecular link between the circadian cycle, glucose homeostasis, and insulin resistance.
O-GlcNAcylation regulates the insulin-signaling pathway at several steps and has been shown to be involved in insulin resistance. Downstream of the insulin-signaling cascade, hyperglycemia targets OGT to O-GlcNAcylate the transcription factor CRTC2, increasing transcription of PGC-1a, which in turn interacts with OGT to target the transferase to FoxO1, resulting in its O-GlcNAcylation and enhanced transcriptional activity. This cascade of events leads to inappropriate gluconeogenesis associated with diabetes. Upstream of the insulin-signaling pathway, OGT is activated by the insulin receptor, translocated to the plasma membrane, and bound to phosphoinositides. The O-GlcNAcylation of IRS1 inhibits phosphorylation required for its interaction with the p85 regulatory subunit of phosphatidylinositol-3-kinase. The phospho-activation of protein kinase B (AKT) at T308 is inhibited by its O-GlcNAcylation, leading to downregulation of AKT function (Ma and Hart, 2013) . GSK3b activity is inhibited by AKT. Phosphorylation by GSK3b promotes IRS1 degradation. GSK3b is O-GlcNAcylated and regulated by the sugar modification (Lubas and Hanover, 2000) . Interestingly, the inhibitory phosphorylation at S9 of GSK3b shows a robust circadian oscillation (Kaasik et al., 2013) , and the stress-induced S9 phosphorylation is delayed in an OGT null mouse cell line, suggesting that O-GlcNAcylation may link circadian cycle, synthesis of glycogen, and the insulin pathway through GSK3b. Since OGT is activated by GSK3b phosphorylation, it is possible that there may be a synergistic effect between O-GlcNAcylation and GSK3b phosphorylation leading to insulin resistance.
O-GlcNAcylation also appears to regulate glucose metabolism. All enzymes in the glycolytic pathway are substrates for OGT. Yi et al. have shown that OGT overexpression or OGA inhibition lowered the rate of glucose metabolism by decreasing PFK1 activity. The authors mapped the O-GlcNAc site as S529, a highly conserved residue known to be important for allosteric regulation of PFK1 by fructose-2,6-bisphosphate. Inhibition of PFK1 by O-GlcNAcylation redirects glucose flux from the glycolytic pathway to the oxidative pentose phosphate pathway, which has been proposed to benefit cancer cell growth (Yi et al., 2012) . Yi et al. also observed that increased O-GlcNAcylation reduced cellular ATP concentrations, suggesting a relationship between the sugar modification and energy production. This effect might in part be due to decreased glycolytic flux, but not entirely, since members of mitochondrial respiratory chain complexes are also O-GlcNAcylated, such as the subunit NDUFA9 of complex I, core 1 and 2 of complex III, and subunit COX I of complex IV. Hyperglycemia increases mitochondrial O-GlcNAcylation and leads to impaired activity of complex I, III, and IV, which results in lower cellular ATP content (Ma and Hart, 2013) .
Reduced glucose metabolism contributes to the etiology of neurodegeneration. Several studies have shown that reduced O-GlcNAcylation of neural proteins, such as the tau protein, neurofilaments, and synaptic vesicle proteins, and their concomitant increased phosphorylation contribute directly to the etiology of Alzhemier's disease (AD). Inhibitors of OGA, which help maintain or increase O-GlcNAcylation in the brain, may prove useful for the treatment of AD (Hart et al., 2011) . Clearly, understanding more fully the ties that exist between nutrient sensing by O-GlcNAcylation, phosphorylation, circadian rhythm regulation, cell cycle, and metabolism will provide novel approaches regarding treatment of obesity, diabetes, cancer, and AD.
Conclusions
It is clear that HBP, O-GlcNAcylation, and OGT act as key molecular components to sense nutrient availability. In normal physiological conditions, OGT integrates those changes and transmits the information to many effector proteins involved in myriad cellular processes, such as transcription or signaling. OGT and O-GlcNAcylation regulate cellular processes to maintain homeostasis at different states of nutrient availability. A growing body of evidence links changes in nutritional status, cellular homeostasis, and the establishment of chronic diseases beyond those typically referred to as metabolic-related pathologies. Improper nutrient homeostasis or nutrient excess leads to abnormal O-GlcNAcylation of proteins with corresponding effects on cell signaling and transcription. Prolonged nutrient excess leads to abnormally high protein O-GlcNAcylation. Such hyper-O-GlcNAcylation not only contributes to abnormal regulation of phosphorylation signaling cascades, but also leads to incorrect control of gene expression and chromatin architecture, all of which contribute to nutrient toxicity, as is seen in diabetes. Likewise, defective glucose utilization, which results in abnormally low O-GlcNAcylation, contributes directly to the onset of neurodegeneration. Faulty epigenetic information induced by deregulation of O-GlcNAcylation could also be transmitted to the daughter cells. The latter is particularly important in the light of cancer etiology and the higher risk of cancer in individuals with diabetes and obesity. Future research will need to elucidate how the crosstalk between different PTMs on proteins works in concert to modulate polypeptide functions in response to metabolism and environmental clues. Clearly, understanding how the nutrient sensor, O-GlcNAcylation, controls signaling pathways and cellular processes and how it crosstalks with other PTMs will be essential not only in understanding cellular physiology but also in the development of new therapeutics.
